Can Eye Injections Damage My Kidneys?
When Eye or Body Symptoms After an Injection Are an Emergency
Most people feel only mild grit or redness after an eye injection. That is normal and settles. But a few signs mean you should be seen the same day. Call your eye doctor right away, or go to an emergency room, if you notice any of these in the days after an injection:
- Severe eye pain, or pain that keeps growing
- More redness, or new light sensitivity
- Decreased vision or new blur
- Sudden heavy swelling in your legs, face, or body
- Signs of very high blood pressure, like a bad headache or chest pain
- You pass much less urine than normal
These first signs can mean a rare but serious eye infection called endophthalmitis1. Here is the calm part. A bad eye infection is not common. It is treated fast because quick care gives the best chance to save sight. The kidney signs are rare too. Getting checked early keeps a small problem small. So do not wait it out at home.
An eye infection can move quickly, so hours matter. Endophthalmitis often shows up within about a week of an eye procedure, and it is a medical emergency that needs treatment as soon as possible to improve the chances of recovery1. If you are unsure whether your symptoms are normal soreness or something more, it is always reasonable to call the office that gave your injection and describe what you feel. They would rather hear from you early.
It helps to know what is expected. Mild redness at the injection spot, a scratchy feeling, and a few floaters for a day or two are common and usually settle on their own. The emergency signs above are the exceptions, not the rule. Knowing the difference lets you relax about ordinary healing while still acting fast on the handful of symptoms that genuinely need same-day care.
Can Eye Injections Damage Your Kidneys? The Short Answer
For most people, the honest answer is that eye injections are unlikely to meaningfully harm the kidneys, but the risk is not zero for everyone. Only a small amount of the medicine leaves the eye and enters the bloodstream. In a real-world study of people with diabetes, most had no worsening of kidney function after anti-VEGF injections2. At the same time, researchers have reported kidney problems in a minority of patients, so the picture is one of generally low risk rather than no risk.
The concern is not spread evenly. The serious kidney reactions that have been reported occur mostly in people who already have kidney disease, high blood pressure, or protein in their urine3. If that describes you, it does not mean you should avoid treatment your eyes need. It means the risk is worth a conversation with your eye doctor and the clinician who manages your kidneys or blood pressure, and worth some simple monitoring along the way.
What These Injections Are, and How the Medicine Reaches Your Body
These are anti-VEGF injections, a medicine that blocks a protein called VEGF (which drives leaky, abnormal blood vessels in the retina). Eye doctors use them for wet age-related macular degeneration, diabetic retinopathy, swelling of the retina called macular edema, and retinal vein occlusion, and they are considered safe and effective4. The medicine is placed into the eye through the white part with a very thin needle, so nearly all of its effect stays where the disease is.
The eye is not perfectly sealed off from the rest of the body. A small amount of an anti-VEGF drug can pass from the eye into the bloodstream, where it briefly lowers the level of free VEGF circulating in your body. For most people this passing dip causes no noticeable problem. The question researchers are studying is whether, in certain people, that small systemic effect is enough to affect organs that rely on VEGF, including the kidneys.
VEGF is not only an eye protein. It also helps maintain the tiny filters in your kidneys that clean your blood. When VEGF is blocked strongly throughout the body, as happens with much larger anti-VEGF doses given by vein for cancer, those filters can be affected, leading to protein in the urine and higher blood pressure. Eye injections use far smaller amounts, which is why any kidney effect is much less likely, but the same biology explains why the question is worth asking.
Signs Your Kidneys Might Be Affected
Early kidney strain is often silent, but some clues can appear. Watch for foamy or bubbly urine (a sign of protein leaking through, called proteinuria), new or worsening swelling in your ankles, feet, or around your eyes, blood pressure readings that climb higher than your usual numbers, or feeling unusually tired. None of these prove a kidney problem on their own, and each has many other causes, but together they are a reason to get simple tests done.
If you have diabetes or high blood pressure, some of these same signs can come from those conditions rather than from an injection. That overlap is exactly why guessing at home does not work well. A urine test for protein and a blood test of kidney function (a number called eGFR) can sort out what is happening far better than symptoms alone. If you notice the changes above, the useful next step is a check, not alarm.
Why an Eye Injection Could Affect the Kidneys at All
Each kidney holds about a million tiny filtering units, and the cells that keep those filters watertight depend on a steady supply of VEGF. Blocking VEGF can loosen that seal, which is how protein starts leaking into the urine and how blood pressure can rise. With an eye injection the amount reaching the kidney is small and brief, so this effect is usually minor or absent. In vulnerable kidneys, though, even a small nudge can matter more.
The people most likely to see a kidney effect are those whose filters are already under strain. In reported cases, worsening blood pressure and protein in the urine after eye injections showed up mainly in people who already had high blood pressure or existing kidney disease3. Diabetes adds to this, because it can already be quietly damaging the kidney filters. Knowing which group you fall into is the key to deciding how closely to watch.
How Likely Is Kidney Harm, and What the Studies Show
Everyday practice is reassuring for most patients. In a study of 66 people with diabetes getting anti-VEGF injections, about 12 of every 100 had some decline in kidney function and about 20 of every 100 developed more protein in the urine, while most had no meaningful change2. Importantly, the kidney changes were not linked to how many injections a person received or to which drug was used2. Those with high blood pressure fared worse, which points again to who is most at risk.
Bigger databases raise a note of caution. In a Taiwan study of 48,248 people followed up to 10 years, those who received ranibizumab eye injections developed chronic kidney disease at nearly twice the rate of those who did not, an adjusted hazard ratio of about 1.885. This kind of study can show a link but cannot prove the injections were the cause. The authors noted they lacked blood pressure and urine data and that injected patients were watched more closely, which can inflate an apparent risk5. It is a reason to monitor, not to panic.
The most severe reaction, a rare blood-vessel and kidney injury called thrombotic microangiopathy, is very uncommon. Only around a few dozen cases of serious kidney toxicity after eye injections have been published, and reports in safety databases are sparse3. When drug changes were made, some patients improved, suggesting the effect can be partly reversible. For the average person receiving injections to protect their sight, this level of risk is small and manageable with attention.
Putting the studies together, eye injections carry a low but real potential to affect the kidneys, concentrated in people who already have kidney disease, diabetes with kidney involvement, or high blood pressure. For a sight-threatening eye condition, the benefit of keeping your vision usually outweighs this risk. The sensible response is not to skip treatment but to know your own kidney status and keep an eye on it, especially in the higher-risk groups.
When to Call Your Eye Doctor, Kidney Doctor, or Primary Care
Call the office that gave your injection the same day for severe or worsening eye pain, growing redness, light sensitivity, or a drop in vision, which can signal infection. Seek urgent care for sudden heavy body swelling, symptoms of very high blood pressure such as a severe headache or chest pain, or a sharp drop in urination. These are uncommon, but they are the situations where speed protects both your eye and your kidneys.
If you have kidney disease, diabetes, or high blood pressure, ask your care team about simple checks around your injection schedule: a blood pressure log, a urine test for protein, and an eGFR blood test now and then. This monitoring is low-effort and catches change early, while it is still easy to manage. Bring your eye doctor and your kidney doctor or primary care clinician into the same conversation so nobody is working in the dark.
If you become worried about your kidneys, do not simply skip injections without talking to your eye doctor. Stopping treatment for wet macular degeneration or diabetic eye disease can let vision loss return, sometimes permanently. The better path is a shared decision: your doctors can weigh your kidney numbers against your eye needs, adjust monitoring, and sometimes consider different options, all while keeping your sight protected.
Common Questions About Eye Injections and Your Kidneys
For almost everyone, a single injection is very unlikely to harm the kidneys. Only a small amount of medicine reaches the bloodstream, and studies have not shown a clear kidney effect from occasional or few injections. The people who have run into trouble usually had existing kidney disease, diabetes, or high blood pressure, and even then serious harm is rare. If you have those conditions, mention them to your eye doctor so monitoring can be arranged.
The evidence is mixed, and no single drug stands out clearly as safe for the kidneys in everyday use. In one real-world diabetic study, kidney changes did not differ meaningfully between the different anti-VEGF drugs2. Some drugs do lower body-wide VEGF a bit more than others, but that has not translated into an obvious difference in kidney outcomes for most patients. Your eye doctor chooses a drug mainly based on your eye disease and response.
Not automatically. Diabetic eye disease can cause serious, sometimes permanent vision loss if left untreated, and injections are a main way to protect sight. Having kidney disease means you are in a higher-risk group, so the right move is closer monitoring, not blanket refusal. Ask your eye doctor and kidney doctor to coordinate, track your blood pressure and urine protein, and make the decision together based on your specific numbers and eye condition.
Current evidence does not clearly show that more injections mean more kidney harm. In a real-world diabetic study, kidney changes were not linked to the number of injections a person received2. That said, people who need many injections often have longstanding diabetes, which itself strains the kidneys over time. So it is worth continuing routine kidney checks if you receive ongoing treatment, mainly because of your underlying condition rather than the injections alone.
You can watch for clues, but you cannot diagnose a kidney problem at home. Foamy urine, new swelling, and rising blood pressure readings are worth noting and reporting. Simple home blood pressure monitoring is genuinely useful. But the definitive checks are a urine protein test and an eGFR blood test through your clinic. Think of home observation as a prompt to get tested, not as a substitute for the tests themselves.
More Questions and Next Steps
Whether your kidney numbers recover after treatment is changed varies from person to person, and there is no guarantee. Recovery depends on your baseline kidney health and how much change occurred. This is a decision to make with your doctors, never alone, because stopping eye treatment carries its own risk of losing vision. Your care team can weigh both sides for your situation and decide what is safest for your eyes and kidneys together.
No, they are generally much less risky for the kidneys. Anti-VEGF given by vein for cancer uses far larger, repeated doses that block VEGF throughout the body, and kidney side effects like protein in the urine and high blood pressure are well known there. Eye injections deliver a tiny fraction of that amount into a single eye. The biology is related, but the scale is very different, which is why kidney effects from eye injections are much less common.
There is no proven diet or hydration trick that protects the kidneys specifically from eye injections. The best kidney care is the ordinary kind: keep blood pressure and blood sugar well controlled, take prescribed kidney-protective medicines, stay reasonably hydrated, and avoid unnecessary anti-inflammatory painkillers if your doctor has advised that. Ask your kidney doctor or primary care clinician for guidance tailored to you rather than following general internet advice.
Tell them if you have kidney disease, diabetes, high blood pressure, or protein in your urine, and share the name of the doctor who manages those conditions. Mention any past reaction to anti-VEGF treatment. This lets your eye doctor set up sensible monitoring from the start and coordinate with your other clinicians. A short, honest medical history at the beginning is one of the simplest ways to keep your treatment safe.
- Given my kidney and blood pressure history, what is my personal risk from these injections?
- Should I have a urine protein test and an eGFR blood test before or during treatment?
- How will you and my kidney doctor or primary care clinician coordinate my care?
- What symptoms should make me call you the same day?
- If my kidney numbers change, what are my options for protecting both my eyes and kidneys?
- Cleveland Clinic (2023). Endophthalmitis: Causes, Symptoms and Treatment.
- Journal of Clinical Medicine (PMC10538817) (2023). Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice.
- Kidney Medicine / case review (PMC7577346) (2020). Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors.
- American Academy of Ophthalmology (EyeSmart) (2023). Anti-VEGF Treatments.
- Scientific Reports (PMC11166851) (2024). Intravitreal ranibizumab injection is associated with an increased risk of chronic kidney disease: a population-based study in Taiwan.